全体要約
バクテリオファージ療法市場は、2022年の31百万米ドルから2029年には61百万米ドルに成長すると予測されており、2023年から2029年の間に年平均成長率（CAGR）は10.0%に達する見込みです。市場の主要プレイヤーには、NPO Microgen、Proteon Pharmaceuticals、Phageluxなどがあり、上位3社で約25%のシェアを占めています。北米とヨーロッパが主要市場で、全体の約60%を占めています。
バクテリオファージ療法は、主に動物健康分野で55%のシェアを持ち、主なタイプはDsDNAバクテリオファージで90%以上のシェアを占めています。市場は、経口、外用、注射用のタイプに分かれ、応用分野には臓器移植、細菌感染、アルコール性肝炎などがあります。
関連する質問
3100万米ドル（2022年）
CAGR 10.0%（2023年から2029年）
NPO Microgen, Proteon Pharmaceuticals, Phagelux, Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH, PhagePro, Inc., Adaptive Phage Therapeutics, Inc., EnBiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation
多剤耐性細菌に対する効果, 医療分野での応用の拡大, 動物健康市場の成長
概要
LPI (LP Information)の最新の研究報告書、「バクテリオファージ療法産業予測」では、過去の売上を検討し、2022年の世界のバクテリオファージ療法の総売上をレビューし、2023年から2029年までのバクテリオファージ療法の予測売上について、地域および市場セクターごとの包括的な分析を提供。バクテリオファージ療法の売上は地域、市場セクターおよびサブセクターごとに分解され、世界のバクテリオファージ療法産業についての詳細な分析がUSドル百万単位で提供されています。
このインサイトレポートは、世界のバクテリオファージ療法の状況に関する包括的な分析を提供し、製品セグメンテーション、会社設立、収益、市場シェア、最新の開発、M&A活動に関連する重要なトレンドを強調しています。また、このレポートは、バクテリオファージ療法ポートフォリオと能力、市場参入戦略、市場ポジション、および地理的な展開に焦点を当てた主要なグローバル企業の戦略も分析し、加速する世界のバクテリオファージ療法市場におけるこれらの企業の独自の位置をよりよく理解するための情報を提供。
このインサイトレポートでは、バクテリオファージ療法における主要な市場動向、ドライバー、および影響要因を評価し、タイプ、アプリケーション、地理、そして市場規模別に予測を分解して、浮上する機会のポイントを強調します。数百件のボトムアップの定性的および定量的市場データに基づいた透明な方法論を用いて、この研究予測は、バクテリオファージ療法の現在の状態と将来的な軌道について非常に詳細な見解を提供します。
世界のバクテリオファージ療法市場の規模は、2022年の3100万米ドルから2029年の6100万米ドルに成長すると予測されています。2023年から2029年の間に年平均成長率（CAGR）10.0%で成長する見込みです。
グローバルファージセラピー市場の主要企業にはNPO Microgen、Proteon Pharmaceuticals、Phageluxなどがあります。トップ3の企業はグローバル市場の約25%のシェアを占めています。北米とヨーロッパが主要市場で、彼らはグローバル市場の約60%を占めています。DsDNAバクテリオファージが主なタイプで、シェアは90%以上です。動物健康が主なアプリケーションで、約55%のシェアを保持しています。
このレポートは、製品タイプ、アプリケーション、主要プレーヤー、重要な地域および国別のバクテリオファージ療法市場の包括的な概要、市場シェア、成長機会を示しています。
市場セグメンテーション：
タイプ別のセグメンテーション
口腔
トピカル
親密な
用途別のセグメンテーション
臓器移植
細菌感染
アルコール性肝炎
その他
この報告書は地域別に市場を分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析した結果に基づいて選定されています。
アーマタ・ファーマシューティカルズ社
エリヤヴァ・バイオプレパレーションズ株式会社
フェレキシデスファーマ
インストラリティクス社
ファゲラックス株式会社
ネクスバイオティクス
イノフェージ社
ローカス・バイオサイエンシズ社
テクノファージ
エリゴバイオサイエンスSA
ファゴメドバイオファーマ株式会社
PhagePro株式会社
アダプティブファージセラピューティクス株式会社
エンバイオティックス社
イントデワールド株式会社
バイオエムエックス株式会社
ファイセラピューティクス
フィックスドフェージ株式会社
ミクレオスBV
コンタフェクト社
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのバクテリオファージ療法市場規模、（2018年～2029年）
2.1.2 バクテリオファージ療法市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 バクテリオファージ療法セグメント、タイプ別
2.2.1 オーラル
2.2.2 トピカル
2.2.3 非経口
2.3 バクテリオファージ療法市場規模：タイプ別
2.3.1 バクテリオファージ療法市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルのバクテリオファージ療法市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 バクテリオファージ療法セグメント、用途別
2.4.1 臓器移植
2.4.2 細菌感染症
2.4.3 アルコール性肝炎
2.4.4 その他
2.5 バクテリオファージ療法市場規模：用途別
2.5.1 バクテリオファージ療法市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルのバクテリオファージ療法市場規模、市場シェア（用途別）（2018年～2023年）
3 バクテリオファージ療法市場規模：プレイヤー別
3.1 バクテリオファージ療法市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおけるバクテリオファージ療法市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおけるバクテリオファージ療法市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルのバクテリオファージ療法市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 バクテリオファージ療法、地域別
4.1 バクテリオファージ療法市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおけるバクテリオファージ療法市場規模成長（2018年〜2023年）
4.3 APACにおけるバクテリオファージ療法市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおけるバクテリオファージ療法市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおけるバクテリオファージ療法市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおけるバクテリオファージ療法市場規模、国別（2018年〜2023年）
5.2 アメリカズにおけるバクテリオファージ療法市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおけるバクテリオファージ療法市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるバクテリオファージ療法市場規模、地域別（2018年〜2023年）
6.2 APACにおけるバクテリオファージ療法市場規模、タイプ別（2018年〜2023年）
6.3 APACにおけるバクテリオファージ療法市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパのバクテリオファージ療法 国別（2018年～2023年）
7.2 ヨーロッパにおけるバクテリオファージ療法市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおけるバクテリオファージ療法市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカのバクテリオファージ療法 地域別（2018年～2023年）
8.2 中東・アフリカにおけるバクテリオファージ療法市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおけるバクテリオファージ療法市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルのバクテリオファージ療法市場、市場予測
10.1 グローバルのバクテリオファージ療法、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルのバクテリオファージ療法、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズのバクテリオファージ療法、市場予測
10.1.3 APACのバクテリオファージ療法、市場予測
10.1.4 ヨーロッパのバクテリオファージ療法、市場予測
10.1.5 中東・アフリカのバクテリオファージ療法、市場予測
10.2 アメリカズのバクテリオファージ療法、市場予測（国別）（2024年～2029年）
10.3 APACのバクテリオファージ療法、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパのバクテリオファージ療法、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカのバクテリオファージ療法、市場予測（地域別）（2024年～2029年）
10.6 グローバルのバクテリオファージ療法、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルのバクテリオファージ療法、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Armata Pharmaceuticals, Inc
11.2 Eliava Biopreparations Ltd
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma：企業情報
11.3.2 Pherecydes Pharma：バクテリオファージ療法分野の提供製品
11.3.3 Pherecydes Pharma：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Pherecydes Pharma：主要事業概要
11.3.5 Pherecydes Pharma：直近の展開
11.4 Intralytix, Inc
11.5 Phagelux Inc
11.6 Nextbiotics
11.6.1 Nextbiotics：企業情報
11.6.2 Nextbiotics：バクテリオファージ療法分野の提供製品
11.6.3 Nextbiotics：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.6.4 Nextbiotics：主要事業概要
11.6.5 Nextbiotics：直近の展開
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd：企業情報
11.7.2 InnoPhage, Ltd：バクテリオファージ療法分野の提供製品
11.7.3 InnoPhage, Ltd：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 InnoPhage, Ltd：主要事業概要
11.7.5 InnoPhage, Ltd：直近の展開
11.8 Locus Biosciences, Inc
11.9 TechnoPhage
11.9.1 TechnoPhage：企業情報
11.9.2 TechnoPhage：バクテリオファージ療法分野の提供製品
11.9.3 TechnoPhage：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 TechnoPhage：主要事業概要
11.9.5 TechnoPhage：直近の展開
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA：企業情報
11.10.2 Eligo Bioscience SA：バクテリオファージ療法分野の提供製品
11.10.3 Eligo Bioscience SA：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.10.4 Eligo Bioscience SA：主要事業概要
11.10.5 Eligo Bioscience SA：直近の展開
11.11 Phagomed Biopharma GmbH
11.12 PhagePro, Inc
11.13 Adaptive Phage Therapeutics, Inc
11.14 EnBiotix, Inc
11.15 Intodeworld, Inc
11.16 BiomX Ltd
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics：企業情報
11.17.2 Phi Therapeutics：バクテリオファージ療法分野の提供製品
11.17.3 Phi Therapeutics：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.17.4 Phi Therapeutics：主要事業概要
11.17.5 Phi Therapeutics：直近の展開
11.18 Fixed-phage Ltd
11.19 Micreos BV
11.19.1 Micreos BV：企業情報
11.19.2 Micreos BV：バクテリオファージ療法分野の提供製品
11.19.3 Micreos BV：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.19.4 Micreos BV：主要事業概要
11.19.5 Micreos BV：直近の展開
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation：企業情報
11.20.2 ContraFect Corporation：バクテリオファージ療法分野の提供製品
11.20.3 ContraFect Corporation：バクテリオファージ療法収益・グロスマージンおよび市場シェア（2018年～2023年）
11.20.4 ContraFect Corporation：主要事業概要
11.20.5 ContraFect Corporation：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Bacteriophage Therapy Industry Forecast” looks at past sales and reviews total world Bacteriophage Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Bacteriophage Therapy sales for 2023 through 2029. With Bacteriophage Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bacteriophage Therapy industry.
This Insight Report provides a comprehensive analysis of the global Bacteriophage Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bacteriophage Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bacteriophage Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bacteriophage Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bacteriophage Therapy.
The global Bacteriophage Therapy market size is projected to grow from US$ 31 million in 2022 to US$ 61 million in 2029; it is expected to grow at a CAGR of 10.0% from 2023 to 2029.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacteriophage Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Oral
Topical
Parenteral
Segmentation by application
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Armata Pharmaceuticals, Inc.
Eliava Biopreparations Ltd.
Pherecydes Pharma
Intralytix, Inc.
Phagelux Inc.
Nextbiotics
InnoPhage, Ltd
Locus Biosciences, Inc.
TechnoPhage
Eligo Bioscience SA
Phagomed Biopharma GmbH.
PhagePro, Inc.
Adaptive Phage Therapeutics, Inc.
EnBiotix, Inc.
Intodeworld, Inc.
BiomX Ltd.
Phi Therapeutics
Fixed-phage Ltd.
Micreos BV
ContraFect Corporation
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bacteriophage Therapy Market Size 2018-2029
2.1.2 Bacteriophage Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Bacteriophage Therapy Segment by Type
2.2.1 Oral
2.2.2 Topical
2.2.3 Parenteral
2.3 Bacteriophage Therapy Market Size by Type
2.3.1 Bacteriophage Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Bacteriophage Therapy Market Size Market Share by Type (2018-2023)
2.4 Bacteriophage Therapy Segment by Application
2.4.1 Organ Transplantation
2.4.2 Bacterial Infections
2.4.3 Alcoholic Hepatitis
2.4.4 Other
2.5 Bacteriophage Therapy Market Size by Application
2.5.1 Bacteriophage Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Bacteriophage Therapy Market Size Market Share by Application (2018-2023)
3 Bacteriophage Therapy Market Size by Player
3.1 Bacteriophage Therapy Market Size Market Share by Players
3.1.1 Global Bacteriophage Therapy Revenue by Players (2018-2023)
3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Bacteriophage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Bacteriophage Therapy by Regions
4.1 Bacteriophage Therapy Market Size by Regions (2018-2023)
4.2 Americas Bacteriophage Therapy Market Size Growth (2018-2023)
4.3 APAC Bacteriophage Therapy Market Size Growth (2018-2023)
4.4 Europe Bacteriophage Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Bacteriophage Therapy Market Size Growth (2018-2023)
5 Americas
5.1 Americas Bacteriophage Therapy Market Size by Country (2018-2023)
5.2 Americas Bacteriophage Therapy Market Size by Type (2018-2023)
5.3 Americas Bacteriophage Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bacteriophage Therapy Market Size by Region (2018-2023)
6.2 APAC Bacteriophage Therapy Market Size by Type (2018-2023)
6.3 APAC Bacteriophage Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Bacteriophage Therapy by Country (2018-2023)
7.2 Europe Bacteriophage Therapy Market Size by Type (2018-2023)
7.3 Europe Bacteriophage Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bacteriophage Therapy by Region (2018-2023)
8.2 Middle East & Africa Bacteriophage Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Bacteriophage Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Bacteriophage Therapy Market Forecast
10.1 Global Bacteriophage Therapy Forecast by Regions (2024-2029)
10.1.1 Global Bacteriophage Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Bacteriophage Therapy Forecast
10.1.3 APAC Bacteriophage Therapy Forecast
10.1.4 Europe Bacteriophage Therapy Forecast
10.1.5 Middle East & Africa Bacteriophage Therapy Forecast
10.2 Americas Bacteriophage Therapy Forecast by Country (2024-2029)
10.2.1 United States Bacteriophage Therapy Market Forecast
10.2.2 Canada Bacteriophage Therapy Market Forecast
10.2.3 Mexico Bacteriophage Therapy Market Forecast
10.2.4 Brazil Bacteriophage Therapy Market Forecast
10.3 APAC Bacteriophage Therapy Forecast by Region (2024-2029)
10.3.1 China Bacteriophage Therapy Market Forecast
10.3.2 Japan Bacteriophage Therapy Market Forecast
10.3.3 Korea Bacteriophage Therapy Market Forecast
10.3.4 Southeast Asia Bacteriophage Therapy Market Forecast
10.3.5 India Bacteriophage Therapy Market Forecast
10.3.6 Australia Bacteriophage Therapy Market Forecast
10.4 Europe Bacteriophage Therapy Forecast by Country (2024-2029)
10.4.1 Germany Bacteriophage Therapy Market Forecast
10.4.2 France Bacteriophage Therapy Market Forecast
10.4.3 UK Bacteriophage Therapy Market Forecast
10.4.4 Italy Bacteriophage Therapy Market Forecast
10.4.5 Russia Bacteriophage Therapy Market Forecast
10.5 Middle East & Africa Bacteriophage Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Bacteriophage Therapy Market Forecast
10.5.2 South Africa Bacteriophage Therapy Market Forecast
10.5.3 Israel Bacteriophage Therapy Market Forecast
10.5.4 Turkey Bacteriophage Therapy Market Forecast
10.5.5 GCC Countries Bacteriophage Therapy Market Forecast
10.6 Global Bacteriophage Therapy Forecast by Type (2024-2029)
10.7 Global Bacteriophage Therapy Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Armata Pharmaceuticals, Inc.
11.1.1 Armata Pharmaceuticals, Inc. Company Information
11.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered
11.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.1.5 Armata Pharmaceuticals, Inc. Latest Developments
11.2 Eliava Biopreparations Ltd.
11.2.1 Eliava Biopreparations Ltd. Company Information
11.2.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered
11.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eliava Biopreparations Ltd. Main Business Overview
11.2.5 Eliava Biopreparations Ltd. Latest Developments
11.3 Pherecydes Pharma
11.3.1 Pherecydes Pharma Company Information
11.3.2 Pherecydes Pharma Bacteriophage Therapy Product Offered
11.3.3 Pherecydes Pharma Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Pherecydes Pharma Main Business Overview
11.3.5 Pherecydes Pharma Latest Developments
11.4 Intralytix, Inc.
11.4.1 Intralytix, Inc. Company Information
11.4.2 Intralytix, Inc. Bacteriophage Therapy Product Offered
11.4.3 Intralytix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Intralytix, Inc. Main Business Overview
11.4.5 Intralytix, Inc. Latest Developments
11.5 Phagelux Inc.
11.5.1 Phagelux Inc. Company Information
11.5.2 Phagelux Inc. Bacteriophage Therapy Product Offered
11.5.3 Phagelux Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Phagelux Inc. Main Business Overview
11.5.5 Phagelux Inc. Latest Developments
11.6 Nextbiotics
11.6.1 Nextbiotics Company Information
11.6.2 Nextbiotics Bacteriophage Therapy Product Offered
11.6.3 Nextbiotics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Nextbiotics Main Business Overview
11.6.5 Nextbiotics Latest Developments
11.7 InnoPhage, Ltd
11.7.1 InnoPhage, Ltd Company Information
11.7.2 InnoPhage, Ltd Bacteriophage Therapy Product Offered
11.7.3 InnoPhage, Ltd Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 InnoPhage, Ltd Main Business Overview
11.7.5 InnoPhage, Ltd Latest Developments
11.8 Locus Biosciences, Inc.
11.8.1 Locus Biosciences, Inc. Company Information
11.8.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Offered
11.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Locus Biosciences, Inc. Main Business Overview
11.8.5 Locus Biosciences, Inc. Latest Developments
11.9 TechnoPhage
11.9.1 TechnoPhage Company Information
11.9.2 TechnoPhage Bacteriophage Therapy Product Offered
11.9.3 TechnoPhage Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 TechnoPhage Main Business Overview
11.9.5 TechnoPhage Latest Developments
11.10 Eligo Bioscience SA
11.10.1 Eligo Bioscience SA Company Information
11.10.2 Eligo Bioscience SA Bacteriophage Therapy Product Offered
11.10.3 Eligo Bioscience SA Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Eligo Bioscience SA Main Business Overview
11.10.5 Eligo Bioscience SA Latest Developments
11.11 Phagomed Biopharma GmbH.
11.11.1 Phagomed Biopharma GmbH. Company Information
11.11.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered
11.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Phagomed Biopharma GmbH. Main Business Overview
11.11.5 Phagomed Biopharma GmbH. Latest Developments
11.12 PhagePro, Inc.
11.12.1 PhagePro, Inc. Company Information
11.12.2 PhagePro, Inc. Bacteriophage Therapy Product Offered
11.12.3 PhagePro, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 PhagePro, Inc. Main Business Overview
11.12.5 PhagePro, Inc. Latest Developments
11.13 Adaptive Phage Therapeutics, Inc.
11.13.1 Adaptive Phage Therapeutics, Inc. Company Information
11.13.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered
11.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Adaptive Phage Therapeutics, Inc. Main Business Overview
11.13.5 Adaptive Phage Therapeutics, Inc. Latest Developments
11.14 EnBiotix, Inc.
11.14.1 EnBiotix, Inc. Company Information
11.14.2 EnBiotix, Inc. Bacteriophage Therapy Product Offered
11.14.3 EnBiotix, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 EnBiotix, Inc. Main Business Overview
11.14.5 EnBiotix, Inc. Latest Developments
11.15 Intodeworld, Inc.
11.15.1 Intodeworld, Inc. Company Information
11.15.2 Intodeworld, Inc. Bacteriophage Therapy Product Offered
11.15.3 Intodeworld, Inc. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Intodeworld, Inc. Main Business Overview
11.15.5 Intodeworld, Inc. Latest Developments
11.16 BiomX Ltd.
11.16.1 BiomX Ltd. Company Information
11.16.2 BiomX Ltd. Bacteriophage Therapy Product Offered
11.16.3 BiomX Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BiomX Ltd. Main Business Overview
11.16.5 BiomX Ltd. Latest Developments
11.17 Phi Therapeutics
11.17.1 Phi Therapeutics Company Information
11.17.2 Phi Therapeutics Bacteriophage Therapy Product Offered
11.17.3 Phi Therapeutics Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Phi Therapeutics Main Business Overview
11.17.5 Phi Therapeutics Latest Developments
11.18 Fixed-phage Ltd.
11.18.1 Fixed-phage Ltd. Company Information
11.18.2 Fixed-phage Ltd. Bacteriophage Therapy Product Offered
11.18.3 Fixed-phage Ltd. Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Fixed-phage Ltd. Main Business Overview
11.18.5 Fixed-phage Ltd. Latest Developments
11.19 Micreos BV
11.19.1 Micreos BV Company Information
11.19.2 Micreos BV Bacteriophage Therapy Product Offered
11.19.3 Micreos BV Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Micreos BV Main Business Overview
11.19.5 Micreos BV Latest Developments
11.20 ContraFect Corporation
11.20.1 ContraFect Corporation Company Information
11.20.2 ContraFect Corporation Bacteriophage Therapy Product Offered
11.20.3 ContraFect Corporation Bacteriophage Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 ContraFect Corporation Main Business Overview
11.20.5 ContraFect Corporation Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Bacteriophage Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Oral Table 3. Major Players of Topical Table 4. Major Players of Parenteral Table 5. Bacteriophage Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 6. Global Bacteriophage Therapy Market Size by Type (2018-2023) & ($ Millions) Table 7. Global Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Table 8. Bacteriophage Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global Bacteriophage Therapy Market Size by Application (2018-2023) & ($ Millions) Table 10. Global Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Table 11. Global Bacteriophage Therapy Revenue by Players (2018-2023) & ($ Millions) Table 12. Global Bacteriophage Therapy Revenue Market Share by Player (2018-2023) Table 13. Bacteriophage Therapy Key Players Head office and Products Offered Table 14. Bacteriophage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Bacteriophage Therapy Market Size by Regions 2018-2023 & ($ Millions) Table 18. Global Bacteriophage Therapy Market Size Market Share by Regions (2018-2023) Table 19. Global Bacteriophage Therapy Revenue by Country/Region (2018-2023) & ($ millions) Table 20. Global Bacteriophage Therapy Revenue Market Share by Country/Region (2018-2023) Table 21. Americas Bacteriophage Therapy Market Size by Country (2018-2023) & ($ Millions) Table 22. Americas Bacteriophage Therapy Market Size Market Share by Country (2018-2023) Table 23. Americas Bacteriophage Therapy Market Size by Type (2018-2023) & ($ Millions) Table 24. Americas Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Table 25. Americas Bacteriophage Therapy Market Size by Application (2018-2023) & ($ Millions) Table 26. Americas Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Table 27. APAC Bacteriophage Therapy Market Size by Region (2018-2023) & ($ Millions) Table 28. APAC Bacteriophage Therapy Market Size Market Share by Region (2018-2023) Table 29. APAC Bacteriophage Therapy Market Size by Type (2018-2023) & ($ Millions) Table 30. APAC Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Table 31. APAC Bacteriophage Therapy Market Size by Application (2018-2023) & ($ Millions) Table 32. APAC Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Table 33. Europe Bacteriophage Therapy Market Size by Country (2018-2023) & ($ Millions) Table 34. Europe Bacteriophage Therapy Market Size Market Share by Country (2018-2023) Table 35. Europe Bacteriophage Therapy Market Size by Type (2018-2023) & ($ Millions) Table 36. Europe Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Table 37. Europe Bacteriophage Therapy Market Size by Application (2018-2023) & ($ Millions) Table 38. Europe Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Table 39. Middle East & Africa Bacteriophage Therapy Market Size by Region (2018-2023) & ($ Millions) Table 40. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Region (2018-2023) Table 41. Middle East & Africa Bacteriophage Therapy Market Size by Type (2018-2023) & ($ Millions) Table 42. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Table 43. Middle East & Africa Bacteriophage Therapy Market Size by Application (2018-2023) & ($ Millions) Table 44. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Table 45. Key Market Drivers & Growth Opportunities of Bacteriophage Therapy Table 46. Key Market Challenges & Risks of Bacteriophage Therapy Table 47. Key Industry Trends of Bacteriophage Therapy Table 48. Global Bacteriophage Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 49. Global Bacteriophage Therapy Market Size Market Share Forecast by Regions (2024-2029) Table 50. Global Bacteriophage Therapy Market Size Forecast by Type (2024-2029) & ($ Millions) Table 51. Global Bacteriophage Therapy Market Size Forecast by Application (2024-2029) & ($ Millions) Table 52. Armata Pharmaceuticals, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 53. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Offered Table 54. Armata Pharmaceuticals, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 55. Armata Pharmaceuticals, Inc. Main Business Table 56. Armata Pharmaceuticals, Inc. Latest Developments Table 57. Eliava Biopreparations Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 58. Eliava Biopreparations Ltd. Bacteriophage Therapy Product Offered Table 59. Eliava Biopreparations Ltd. Main Business Table 60. Eliava Biopreparations Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 61. Eliava Biopreparations Ltd. Latest Developments Table 62. Pherecydes Pharma Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 63. Pherecydes Pharma Bacteriophage Therapy Product Offered Table 64. Pherecydes Pharma Main Business Table 65. Pherecydes Pharma Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 66. Pherecydes Pharma Latest Developments Table 67. Intralytix, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 68. Intralytix, Inc. Bacteriophage Therapy Product Offered Table 69. Intralytix, Inc. Main Business Table 70. Intralytix, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 71. Intralytix, Inc. Latest Developments Table 72. Phagelux Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 73. Phagelux Inc. Bacteriophage Therapy Product Offered Table 74. Phagelux Inc. Main Business Table 75. Phagelux Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 76. Phagelux Inc. Latest Developments Table 77. Nextbiotics Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 78. Nextbiotics Bacteriophage Therapy Product Offered Table 79. Nextbiotics Main Business Table 80. Nextbiotics Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 81. Nextbiotics Latest Developments Table 82. InnoPhage, Ltd Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 83. InnoPhage, Ltd Bacteriophage Therapy Product Offered Table 84. InnoPhage, Ltd Main Business Table 85. InnoPhage, Ltd Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 86. InnoPhage, Ltd Latest Developments Table 87. Locus Biosciences, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 88. Locus Biosciences, Inc. Bacteriophage Therapy Product Offered Table 89. Locus Biosciences, Inc. Main Business Table 90. Locus Biosciences, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 91. Locus Biosciences, Inc. Latest Developments Table 92. TechnoPhage Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 93. TechnoPhage Bacteriophage Therapy Product Offered Table 94. TechnoPhage Main Business Table 95. TechnoPhage Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 96. TechnoPhage Latest Developments Table 97. Eligo Bioscience SA Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 98. Eligo Bioscience SA Bacteriophage Therapy Product Offered Table 99. Eligo Bioscience SA Main Business Table 100. Eligo Bioscience SA Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 101. Eligo Bioscience SA Latest Developments Table 102. Phagomed Biopharma GmbH. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 103. Phagomed Biopharma GmbH. Bacteriophage Therapy Product Offered Table 104. Phagomed Biopharma GmbH. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 105. Phagomed Biopharma GmbH. Main Business Table 106. Phagomed Biopharma GmbH. Latest Developments Table 107. PhagePro, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 108. PhagePro, Inc. Bacteriophage Therapy Product Offered Table 109. PhagePro, Inc. Main Business Table 110. PhagePro, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 111. PhagePro, Inc. Latest Developments Table 112. Adaptive Phage Therapeutics, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 113. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Offered Table 114. Adaptive Phage Therapeutics, Inc. Main Business Table 115. Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 116. Adaptive Phage Therapeutics, Inc. Latest Developments Table 117. EnBiotix, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 118. EnBiotix, Inc. Bacteriophage Therapy Product Offered Table 119. EnBiotix, Inc. Main Business Table 120. EnBiotix, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 121. EnBiotix, Inc. Latest Developments Table 122. Intodeworld, Inc. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 123. Intodeworld, Inc. Bacteriophage Therapy Product Offered Table 124. Intodeworld, Inc. Main Business Table 125. Intodeworld, Inc. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 126. Intodeworld, Inc. Latest Developments Table 127. BiomX Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 128. BiomX Ltd. Bacteriophage Therapy Product Offered Table 129. BiomX Ltd. Main Business Table 130. BiomX Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 131. BiomX Ltd. Latest Developments Table 132. Phi Therapeutics Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 133. Phi Therapeutics Bacteriophage Therapy Product Offered Table 134. Phi Therapeutics Main Business Table 135. Phi Therapeutics Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 136. Phi Therapeutics Latest Developments Table 137. Fixed-phage Ltd. Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 138. Fixed-phage Ltd. Bacteriophage Therapy Product Offered Table 139. Fixed-phage Ltd. Main Business Table 140. Fixed-phage Ltd. Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 141. Fixed-phage Ltd. Latest Developments Table 142. Micreos BV Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 143. Micreos BV Bacteriophage Therapy Product Offered Table 144. Micreos BV Main Business Table 145. Micreos BV Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 146. Micreos BV Latest Developments Table 147. ContraFect Corporation Details, Company Type, Bacteriophage Therapy Area Served and Its Competitors Table 148. ContraFect Corporation Bacteriophage Therapy Product Offered Table 149. ContraFect Corporation Main Business Table 150. ContraFect Corporation Bacteriophage Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 151. ContraFect Corporation Latest Developments List of Figures Figure 1. Bacteriophage Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Bacteriophage Therapy Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Bacteriophage Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Bacteriophage Therapy Sales Market Share by Country/Region (2022) Figure 8. Bacteriophage Therapy Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Bacteriophage Therapy Market Size Market Share by Type in 2022 Figure 10. Bacteriophage Therapy in Organ Transplantation Figure 11. Global Bacteriophage Therapy Market: Organ Transplantation (2018-2023) & ($ Millions) Figure 12. Bacteriophage Therapy in Bacterial Infections Figure 13. Global Bacteriophage Therapy Market: Bacterial Infections (2018-2023) & ($ Millions) Figure 14. Bacteriophage Therapy in Alcoholic Hepatitis Figure 15. Global Bacteriophage Therapy Market: Alcoholic Hepatitis (2018-2023) & ($ Millions) Figure 16. Bacteriophage Therapy in Other Figure 17. Global Bacteriophage Therapy Market: Other (2018-2023) & ($ Millions) Figure 18. Global Bacteriophage Therapy Market Size Market Share by Application in 2022 Figure 19. Global Bacteriophage Therapy Revenue Market Share by Player in 2022 Figure 20. Global Bacteriophage Therapy Market Size Market Share by Regions (2018-2023) Figure 21. Americas Bacteriophage Therapy Market Size 2018-2023 ($ Millions) Figure 22. APAC Bacteriophage Therapy Market Size 2018-2023 ($ Millions) Figure 23. Europe Bacteriophage Therapy Market Size 2018-2023 ($ Millions) Figure 24. Middle East & Africa Bacteriophage Therapy Market Size 2018-2023 ($ Millions) Figure 25. Americas Bacteriophage Therapy Value Market Share by Country in 2022 Figure 26. United States Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 27. Canada Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 28. Mexico Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 29. Brazil Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 30. APAC Bacteriophage Therapy Market Size Market Share by Region in 2022 Figure 31. APAC Bacteriophage Therapy Market Size Market Share by Type in 2022 Figure 32. APAC Bacteriophage Therapy Market Size Market Share by Application in 2022 Figure 33. China Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 34. Japan Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 35. Korea Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 36. Southeast Asia Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 37. India Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 38. Australia Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 39. Europe Bacteriophage Therapy Market Size Market Share by Country in 2022 Figure 40. Europe Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Figure 41. Europe Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Figure 42. Germany Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 43. France Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 44. UK Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 45. Italy Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 46. Russia Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 47. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Region (2018-2023) Figure 48. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Type (2018-2023) Figure 49. Middle East & Africa Bacteriophage Therapy Market Size Market Share by Application (2018-2023) Figure 50. Egypt Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 51. South Africa Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 52. Israel Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 53. Turkey Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 54. GCC Country Bacteriophage Therapy Market Size Growth 2018-2023 ($ Millions) Figure 55. Americas Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 56. APAC Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 57. Europe Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 58. Middle East & Africa Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 59. United States Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 60. Canada Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 61. Mexico Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 62. Brazil Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 63. China Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 64. Japan Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 65. Korea Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 66. Southeast Asia Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 67. India Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 68. Australia Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 69. Germany Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 70. France Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 71. UK Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 72. Italy Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 73. Russia Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 74. Spain Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 75. Egypt Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 76. South Africa Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 77. Israel Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 78. Turkey Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 79. GCC Countries Bacteriophage Therapy Market Size 2024-2029 ($ Millions) Figure 80. Global Bacteriophage Therapy Market Size Market Share Forecast by Type (2024-2029) Figure 81. Global Bacteriophage Therapy Market Size Market Share Forecast by Application (2024-2029)
